Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 946

1.

Abstracts of the 8th Conference on Progress in Etiopathogenesis of Seizures. Lublin, Poland, 21 November 2003.

[No authors listed]

Pol J Pharmacol. 2004 Jan-Feb;56(1):145-53. No abstract available.

PMID:
15988860
2.

Influence of beta-adrenergic antagonists on tear secretion in children.

Samochowiec-Donocik E, Koraszewska-Matuszewska B.

Pol J Pharmacol. 2004 Nov-Dec;56(6):871-3.

3.

Intraamygdaloid administration of BIBO 3304 increases water intake and extends anxiolytic effects.

Wierońska JM, Stachowicz K, Kłodzińska A, Smiałowska M, Pilc A.

Pol J Pharmacol. 2004 Nov-Dec;56(6):867-70.

4.

Selective mGlu5 receptor antagonist MTEP attenuates naloxone-induced morphine withdrawal symptoms.

Pałucha A, Brański P, Pilc A.

Pol J Pharmacol. 2004 Nov-Dec;56(6):863-6.

5.
6.

Effect of metyrapone supplementation on imipramine therapy in patients with treatment-resistant unipolar depression.

Rogóz Z, Skuza G, Wójcikowski J, Daniel WA, Wróbel A, Dudek D, Zieba A.

Pol J Pharmacol. 2004 Nov-Dec;56(6):849-55.

7.
8.

Influence of antidepressant drugs on macrophage cytotoxic activity in rats.

Belowski D, Kowalski J, Madej A, Herman ZS.

Pol J Pharmacol. 2004 Nov-Dec;56(6):837-42.

9.

Chronic treatment with citalopram does not affect the expression of alpha1-adrenergic receptor (alpha1-AR) subtypes.

Kreiner G, Bielawski A, Zelek-Molik A, Kowalska M, Nalepa I.

Pol J Pharmacol. 2004 Nov-Dec;56(6):831-6.

10.

Effect of imipramine treatment on plasma dopamine beta-hydroxylase activity in chronic mild stress in rats.

Grabowska M, Schlegel-Zawadzka M, Papp M, Nowak G.

Pol J Pharmacol. 2004 Nov-Dec;56(6):825-9.

11.

Effect of administration of alendronate sodium and retinol on the mechanical properties of the femur in ovariectomized rats.

Sliwiński L, Janiec W, Pytlik M, Folwarczna J, Kaczmarczyk-Sedlak I, Pytlik W, Cegieła U, Nowińska B.

Pol J Pharmacol. 2004 Nov-Dec;56(6):817-24.

13.

Role of adrenal gland hormones in the mechanism of antiulcer action of nimesulide and ranitidine.

Süleyman H, Demircan B, Göçer F, Halici Z, Hacimüftüoğlu A.

Pol J Pharmacol. 2004 Nov-Dec;56(6):799-804.

14.

Hypoxic and pharmacological preconditioning preserves vasomotor response of porcine coronary artery.

Kuzner J, Drevensek G, Gersak B, Budihna M.

Pol J Pharmacol. 2004 Nov-Dec;56(6):789-97.

15.

Effect of simvastatin and fluvastatin on plasma fibrinogen levels in patients with primary hypercholesterolemia.

Okopień B, Krysiak R, Madej A, Belowski D, Zieliński M, Kowalski J, Herman ZS.

Pol J Pharmacol. 2004 Nov-Dec;56(6):781-7.

16.

Anti-inflammatory effects of selective COX-2 inhibitors.

Süleyman H, Demircan B, Karagöz Y, Oztaşan N, Süleyman B.

Pol J Pharmacol. 2004 Nov-Dec;56(6):775-80.

17.

Antiarrhythmic profile and endothelial action of novel decahydroquinoline derivatives.

Kozlovski VI, Vdovichenko VP, Chlopicki S, Malchik SS, Praliyev KD, Zcilkibayev OT.

Pol J Pharmacol. 2004 Nov-Dec;56(6):767-74.

18.

Synthesis and cardiovascular activity of new 8-alkylamino-1,3-dimethyl-7-(2-hydroxy-3- piperazinopropyl)-3,7-dihydro-1H-purine-2,6-diones.

Chłoń-Rzepa G, Pawłowski M, Zygmunt M, Filipek B, Maciag D.

Pol J Pharmacol. 2004 Nov-Dec;56(6):755-66.

19.

New 4-[omega-(diarylmethylamino)alkyl]- and 4-[omega-(diarylmethoxy)alkyl]-1-arylpiperazines as selective 5-HT1A/5-HT2A receptor ligands with differentiated in vivo activity.

Paluchowska MH, Charakchieva-Minol S, Tatarczyńska E, Kłodzińska A, Stachowicz K, Chojnacka-Wójcik E.

Pol J Pharmacol. 2004 Nov-Dec;56(6):743-54.

20.

Effects of joint administration of imipramine and amantadine in patients with drug-resistant unipolar depression.

Rogóz Z, Dziedzicka-Wasylewska M, Daniel WA, Wójcikowski J, Dudek D, Wróbel A, Zieba A.

Pol J Pharmacol. 2004 Nov-Dec;56(6):735-42.

Supplemental Content

Loading ...
Support Center